Tag: Pharma
Abionyx Pharma: 1.9 million euros in cash in the first half
(AOF) – Abionyx Pharma, a new generation biotech dedicated to the discovery and development of innovative therapies, recorded consolidated half-year sales of 2.1 million euros, after elimination of intra-group transactions.…
In the United States, Big Pharma at the heart of the drug price storm
An activist with a sign “Be a Hero”, an organization in favor of controlling the price of drugs in the United States, in front of the Capitol, in Washington, on…
MaaT Pharma joins the Microbiome Therapeutics Innovation Group – 07/20/2023 at 18:23
MaaT Pharma (EURONEXT: MAAT – the “Company”), a late-stage biotechnology company, leader in the development of Microbiome Ecosystem TherapiesTM (MET) aimed at improving the survival of cancer patients, announces today…
Sanofi: Strategic collaboration with Recludix Pharma
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Medesis Pharma presents a poster at the AAIC international conference
By Alexandra Saintpierre Published on 07/14/2023 at 2:52 p.m. Photo credit © NissierPictures (Boursier.com) — The pharmaceutical biotechnology…
TME Pharma: a tumor has completely disappeared in a patient
AB Published on 07/13/2023 at 08:37 (Boursier.com) — TME Pharma Announces Positive Best Response Clinical Update, Reporting Patient Complete Response…
MEDESIS PHARMA PRESENTS A SCIENTIFIC POSTER AT THE INTERNATIONAL CONFERENCE OF THE ALZHEIMER ASSOCIATION IN AMSTERDAM – 07/13/2023 at 18:00
MEDESIS PHARMA PRESENTS A SCIENTIFIC POSTER AT THE INTERNATIONAL CONFERENCE OF THE ALZHEIMER ASSOCIATION IN AMSTERDAM Final recruitment stage of the Nanolithium study in the fall of 2023, first results…
Medesis Pharma: appeals the judgment of the TC of Montpellier in the legal dispute with Bpifrance
By Alexandra Saintpierre Published on 07/06/2023 at 6:48 p.m. Photo credit © NissierPictures (Boursier.com) — The pharmaceutical biotechnology…
Medesis pharma: Medesis’ nuclear radiation treatment is protected by a patent in the United States
(BFM Bourse) – The Montpellier biotech has received an agreement to issue a patent in the United States protecting, for 20 years, the property of NanoManganese, its drug candidate intended…
Medesis Pharma on the rise after the registration of a patent in the United States – 07/04/2023 at 11:11
(AOF) – Medesis Pharma gains 5.54% to 1.43 euro after having received the agreement (“Notice of Allowance”) for the registration in the United States of its patent protecting for 20…
TME Pharma: positive results in brain tumors – 06/30/2023 at 18:02
(CercleFinance.com) – TME Pharma announced on Wednesday that a study had shown that 83% of patients with glioblastoma, a brain cancer, were still alive after 15 months of treatment, “unheard…
TME Pharma: positive results in brain tumors
(CercleFinance.com) – TME Pharma announced on Wednesday that a study had shown that 83% of patients with glioblastoma, a brain cancer, were still alive after 15 months of treatment, “unheard…